Literature DB >> 24854403

The clinical significance of cytology versus histology-based diagnosis in small cell lung cancer: a retrospective study.

Alexios Strimpakos1, Ekaterini Politi1, Elias Kainis1, Dimitra Grapsa1, Spiros Siolos1, Sofia Tsagouli1, Rodoula Trigidou2, Konstantinos Syrigos3.   

Abstract

OBJECTIVES: The aim of this study was to investigate the clinical significance of cytology versus histology-based diagnosis among patients diagnosed with small cell lung cancer (SCLC).
MATERIALS AND METHODS: Retrospective analysis of medical records of 443 patients with histologically or cytologically confirmed small cell lung carcinoma (SCLC) was performed. All patients received platinum-based chemotherapy regimens. Survival data (overall survival) were compared between patients with histology or cytology-based diagnosis in the overall study population as well as after stratification of patients according to disease stage (limited or extensive) at the time of diagnosis.
RESULTS: Distribution of demographics and clinicopathological characteristics among the two groups ("histology" and "cytology") was similar. No statistically significant differences in the survival curves between the "histology" and "cytology" groups were found in the overall study population (log rank test, p=0.237), as well as in the subgroup of patients with limited disease (log rank test, p=0.474). In contrast, patients with histology-based diagnosis had a statistically significant longer survival as compared to those with cytology-based diagnosis in the extensive disease subgroup (log rank test, p=0.031), but this association was not retained after adjusting the analysis for demographics and clinical characteristics via a Cox regression model (HR=1.18, 95% CI: 0.96-1.44, p=0.110).
CONCLUSION: The results of our study suggest that the type of diagnostic modality employed (histology or cytology-based) for the establishment of a diagnosis of SCLC may not have a significant effect on the overall survival of patients. Further studies are warranted to further investigate this important, yet rather unexplored, issue.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytology; Diagnostic accuracy; Histology; Prognosis; Small cell lung carcinoma (SCLC); Survival

Mesh:

Year:  2014        PMID: 24854403     DOI: 10.1016/j.lungcan.2014.04.015

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  1 in total

1.  Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.

Authors:  Leilei Liu; Ping Zhan; Xiaodie Zhou; Yong Song; Xiaojun Zhou; Like Yu; Jiandong Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.